Dr. Christopher R. Ellis, MD, FACC, FHRS.
Christopher R. Ellis, MD, FACC, FHRS completed medical school at University of Rochester, NY in 2000. He completed Internal Medicine-Pediatrics residency at Vanderbilt Medical Center and was appointed the Hugh J. Morgan Chief Resident for Internal Medicine 2004-2005. His Cardiovascular Medicine Fellowship at Vanderbilt Heart and Vascular Institute spanned 2005-2008. Dr. Ellis then worked under Dr. Fred Morady at University of Michigan 2008-2009 completing Clinical Cardiac Electrophysiology Fellowship before re-joining Vanderbilt Heart and Vascular Institute in July 2009 as Assistant Professor of Medicine.
He has since expanded his clinical practice to reach a referral base for the greater Southeastern US in complex left atrial catheter ablation, laser lead extraction, and left atrial appendage ligation. He helped create the hybrid AF surgical ablation program at Vanderbilt alongside colleagues Steven J. Hoff and S. Patrick Whalen, and continues to work with Atricure ,Inc., to design clinical trials for longstanding persistent AF ablation (DEEP hybrid AF), and left atrial appendage ligation for stroke prevention. He has created the Left Atrial Appendage Closure (LAAC- LARIAT and Watchman) program at Vanderbilt, and is helping design a prospective randomized trial of LARIAT (Sentre Heart, Inc.) LAA ligation, plus catheter ablation, versus catheter ablation alone, for persistent AF treatment.
Looking forward, goals for Dr. Ellis include continued advancement of AF therapy, including unique collaboration in translational genomics work at Vanderbilt, and helping spearhead the landmark clinical trials to prove that ligation of the LAA prevents stroke in AF patients.